康诺亚生物医药科技有限公司（康诺亚-B，股票代码：02162）于2026年8月3日披露了截至2026年7月31日的证券变动月报。报告显示，公司法定股本与已发行股本在本月内均保持不变。
根据公告，康诺亚-B的法定注册股本总额为500,000,000股，面值为每股USD 0.0001，对应注册股本为USD 50,000。本月末已发行股份数量为298,735,566股，与上月底的298,735,566股一致，库藏股余额为0股。公司未发生新的股份发行、购回股份、注销或增发行为，亦无股份期权、认股权证或可换股票据的变动。
康诺亚-B确认其公众持股量符合香港联交所《上市规则》关于最低公众持股量的要求。截至报告期末，公司总股本保持稳定。
公告由执行董事Bo CHEN博士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.